The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin

Interindividual variation in response to metformin, first-line therapy for type 2 diabetes, is substantial. Given that transporters are determinants of metformin pharmacokinetics, we examined the effects of promoter variants in both multidrug and toxin extrusion protein 1 (MATE1) (g.−66T→C, rs225228...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Stocker, Sophie L., Morrissey, Kari M., Yee, Sook Wah, Castro, Richard A., Xu, Lu, Dahlin, Amber, Ramirez, Andrea H., Roden, Dan M., Wilke, Russ A., McCarty, Cathy A., Davis, Robert L., Brett, Claire M., Giacomini, Kathleen M.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671611/
https://ncbi.nlm.nih.gov/pubmed/23267855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2012.210
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars